Home Tools
Log in
Cart

Search Result

Search Results for " ly 333328 "

2

Compounds

Cat No. Product Name Synonyms Targets
T37881 Oritavancin(LY-333328)
Oritavancin is a novel semisynthetic glycopeptide antibiotics. On August 6, 2014, the FDA approved oritavancin for treatment of skin infections. Oritavancin possesses potent and rapid bactericidal activity in vitro again...
T2691 Oritavancin diphosphate LY333328 diphosphate Others , Antibacterial , Antibiotic
Oritavancin diphosphate (LY333328 diphosphate) is a novel semisynthetic glycopeptide antibiotic which is being developed for the treatment of serious Gram-positive bacterial infections.
TargetMol